PE-VC Fund Investments
Drug discovery platform Peptris raises Rs.70-Cr from IAN Alpha, Speciale Invest, others
Bengaluru-based Peptris has raised INR 70 crore (USD 7.7 million) in a Series A funding round co-led by IAN Alpha Fund and Speciale Invest, with participation from Tenacity Ventures, BYT Ventures, and other investors.Founded in 2019 by Narayanan Venkatasubramanian, Shridhar Narayanan, Anand Budni, and Amit Mahajan, Peptris develops artificial intelligence models that generate novel molecules and predict key drug development parameters. It focuses on therapeutic areas such as rare diseases, inflammation, oncology, and women's health and operates a B2B (business-to-business) model, partnering with pharmaceutical and biotechnology firms to license assets and co-develop programs targeting global markets.The company plans to use the new capital to support its research programs, strengthen scientific and technology teams, advance existing programs toward clinical readiness, and expand its discovery pipeline over the next 24 months.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
